Each CLARINASE REPETABS Tablet contains 5 mg loratadine in the tablet coating and 120 mg pseudoephedrine sulfate equally distributed between the tablet coating and the barrier-coated core. The two active components in the coating are quickly liberated; release of the decongestant in the core is delayed for several hours.
Each ER tab contains loratadine 10 mg in the tablet coating and pseudoephedrine sulfate 240 mg in the tablet core. The loratadine component is released immediately, whereas the pseudoephedrine component is released slowly from the core allowing for once-daily administration.
Excipients/Inactive Ingredients: Repetab: lactose monohydrate, maize starch, povidone, magnesium stearate, acacia, sucrose, calcium sulfate dihydrate, calcium sulfate anhydrous, colophonium, zein, oleic acid, soap powder, talc, microcrystalline cellulose, titanium dioxide, white beeswax, carnauba wax, purified water and ethanol 96%.
ER Tab: Core: Hydroxypropyl methylcellulose, ethylcellulose, dibasic calcium phosphate dihydrate, povidone, silicone dioxide and magnesium stearate.
Film-Coat: Polyethylene glycol, dye opaspray white, sugar, carnauba wax and white wax.